In line with previous results, GNAS proto-oncogene-activating mutations were the most frequent genetic mutation identified in 27 and 4.8% of somatotropinomas and NFPA, respectively (9,12). This evidence concerns the gene GNAS and non-functioning pituitary adenoma.